Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip
Abstract
1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Irish, J.; Kim, J.; Waldron, J.; Wei, A.C.; Winquist, E.; Yoo, J.; Boasie, A.; Brouwers, M.; Meertens, E.; McNair, S.; et al. Organizational Guidance for the Care of Patients with Head-and-Neck Cancer in Ontario. Curr. Oncol. 2020, 27, 115–122. [Google Scholar] [CrossRef] [PubMed]
- Conlon, M.S.C.; Santi, S.A.; Meigs, M.L.; Davidson, S.M.; Saunders, D. Cigarette-Smoking Characteristics and Interest in Cessation in Patients with Head-and-Neck Cancer. Curr. Oncol. 2020, 27, 478–485. [Google Scholar] [CrossRef] [PubMed]
- Riihilä, P.; Nissinen, L.; Knuutila, J.; Rahmati Nezhad, P.; Viiklepp, K.; Kähäri, V.-M. Complement System in Cutaneous Squamous Cell Carcinoma. Int. J. Mol. Sci. 2019, 20, 3550. [Google Scholar] [CrossRef] [PubMed]
- Jeruzal-Świątecka, J.; Pietruszewska, W. Awareness of Human Papillomavirus and Its Oncogenic Potential in Head and Neck Cancer among Students: Still More Questions than Answers. Int. J. Environ. Res. Public Health 2020, 17, 8667. [Google Scholar] [CrossRef] [PubMed]
- Tealab, S.H.; Sedhom, N.F.H.; Hassouna, A.; Gouda, I.; Ismail, H. Prevalence of human papilloma virus in oropharyngeal, tongue and lip squamous cell carcinoma: An experience from the Egyptian National Cancer Institute. J. Investig. Med. 2019, 67, 1061–1066. [Google Scholar] [CrossRef] [PubMed]
- Alsbeih, G.; Al-Harbi, N.; Bin Judia, S.; Al-Qahtani, W.; Khoja, H.; El-Sebaie, M.; Tulbah, A. Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma. Cancers 2019, 11, 820. [Google Scholar] [CrossRef] [PubMed]
- Rakislova, N.; Alemany, L.; Clavero, O.; Saco, A.; Torné, A.; del Pino, M.; Munmany, M.; Rodrigo-Calvo, M.T.; Guerrero, J.; Marimon, L.; et al. p53 Immunohistochemical Patterns in HPV-Independent Squamous Cell Carcinomas of the Vulva and the Associated Skin Lesions: A Study of 779 Cases. Int. J. Mol. Sci. 2020, 21, 8091. [Google Scholar] [CrossRef] [PubMed]
- Perri, F.; Longo, F.; Caponigro, F.; Sandomenico, F.; Guida, A.; Della Vittoria Scarpati, G.; Ottaiano, A.; Muto, P.; Ionna, F. Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat. Cancers 2020, 12, 975. [Google Scholar] [CrossRef] [PubMed]
- Tenore, G.; Nuvoli, A.; Mohsen, A.; Cassoni, A.; Battisti, A.; Terenzi, V.; Della Monaca, M.; Raponi, I.; Brauner, E.; De Felice, F.; et al. Tobacco, Alcohol and Family History of Cancer as Risk Factors of Oral Squamous Cell Carcinoma: Case-Control Retrospective Study. Appl. Sci. 2020, 10, 3896. [Google Scholar] [CrossRef]
- Tampucci, S.; Guazzelli, L.; Burgalassi, S.; Carpi, S.; Chetoni, P.; Mezzetta, A.; Nieri, P.; Polini, B.; Pomelli, C.S.; Terreni, E.; et al. pH-Responsive Nanostructures Based on Surface Active Fatty Acid-Protic Ionic Liquids for Imiquimod Delivery in Skin Cancer Topical Therapy. Pharmaceutics 2020, 12, 1078. [Google Scholar] [CrossRef] [PubMed]
- Shin, S.-H.; Kim, H.-Y.; Yoon, H.-S.; Park, W.-J.; Adams, D.R.; Pyne, N.J.; Pyne, S.; Park, J.-W. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes. Int. J. Mol. Sci. 2020, 21, 8371. [Google Scholar] [CrossRef] [PubMed]
- Aldara EPAR. European Medicines Agency (EMA). Available online: https://www.ema.europa.eu/en/medicines/human/EPAR/aldara (accessed on 24 April 2021).
- Gamez, M.E.; Kraus, R.; Hinni, M.L.; Moore, E.J.; Ma, D.J.; Ko, S.J.; Rwigema, J.C.M.; McGee, L.A.; Halyard, M.Y.; Buras, M.R.; et al. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral. Oncol. 2018, 87, 43–48. [Google Scholar] [CrossRef] [PubMed]
- Rewadkar, M.S.; Mahobia, V.K. Impact of induction chemotherapy to concurrent chemoirradiation over radiotherapy alone in advanced oral cavity. Indian J. Cancer 2017, 54, 16–19. [Google Scholar] [PubMed]
- Love, W.E.; Bernhard, J.D.; Bordeaux, J.S. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: A systematic review. Arch Dermatol. 2009, 145, 1431–1438. [Google Scholar] [CrossRef] [PubMed]
- Cullen, J.K.; Simmons, J.L.; Parsons, P.G.; Boyle, G.M. Topical treatments for skin cancer. Adv. Drug Deliv. Rev. 2020, 153, 54–64. [Google Scholar] [CrossRef] [PubMed]
- Wester, A.; Eyler, J.T.; Swan, J.W. Topical imiquimod for the palliative treatment of recurrent oral squamous cell carcinoma. JAAD Case Rep. 2017, 3, 329–331. [Google Scholar] [CrossRef] [PubMed]
- Smith, K.J.; Germain, M.; Yeager, J.; Skelton, H. Topical 5% imiquimod for the therapy of actinic cheilitis. J. Am. Acad. Dermatol. 2002, 47, 497–501. [Google Scholar] [CrossRef] [PubMed]
- Epstein, E. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil. Arch. Dermatol. 1977, 113, 906–908. [Google Scholar] [CrossRef] [PubMed]
- Kostovic, K.; Gulin, S.J.; Mokos, Z.B.; Ceovic, R. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization. Anticancer Agents Med. Chem. 2017, 17, 1304–1311. [Google Scholar] [CrossRef] [PubMed]
- Yan, J.; Wang, P.; Li, L.; Zhang, L.; Zhang, G.; Tang, Y.; Wang, X. Surgery sequential with 5-Aminolevulinic acid photodynamic therapy for lip squamous cell carcinoma: Two cases reports. Photodiagnosis Photodyn. Ther. 2020, 32, 102043. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pentangelo, G.; Nisticò, S.P.; Provenzano, E.; Cisale, G.Y.; Bennardo, L. Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip. Medicina 2021, 57, 563. https://doi.org/10.3390/medicina57060563
Pentangelo G, Nisticò SP, Provenzano E, Cisale GY, Bennardo L. Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip. Medicina. 2021; 57(6):563. https://doi.org/10.3390/medicina57060563
Chicago/Turabian StylePentangelo, Giovanni, Steven Paul Nisticò, Eugenio Provenzano, Giusy Ylenia Cisale, and Luigi Bennardo. 2021. "Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip" Medicina 57, no. 6: 563. https://doi.org/10.3390/medicina57060563
APA StylePentangelo, G., Nisticò, S. P., Provenzano, E., Cisale, G. Y., & Bennardo, L. (2021). Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip. Medicina, 57(6), 563. https://doi.org/10.3390/medicina57060563